Financial Snapshot

Revenue
$446.7M
TTM
Gross Margin
48.93%
TTM
Net Earnings
-$180.3M
TTM
Current Assets
Q4 2024
Current Liabilities
Q4 2024
Current Ratio
263.03%
Q4 2024
Total Assets
Q4 2024
Total Liabilities
Q4 2024
Book Value
$313.0M
Q4 2024
Cash
Q4 2024
P/E
-1.577
Nov 29, 2024 EST
Free Cash Flow
-$894.0K
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018
Revenue $414.3M $363.1M $310.0M $170.4M $132.5M $94.81M $76.80M
YoY Change 14.09% 17.13% 81.98% 28.57% 39.76% 23.45%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018
Revenue $414.3M $363.1M $310.0M $170.4M $132.5M $94.81M $76.80M
Cost Of Revenue $221.5M $198.9M $169.0M $93.67M $73.70M $60.60M $53.40M
Gross Profit $192.7M $164.2M $141.0M $76.69M $58.80M $34.20M $23.40M
Gross Profit Margin 46.52% 45.23% 45.48% 45.01% 44.38% 36.07% 30.47%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018
Selling, General & Admin $162.2M $180.3M $185.9M $65.30M $56.20M $43.12M $74.90M
YoY Change -10.06% -2.99% 184.66% 16.18% 30.34% -42.43%
% of Gross Profit 84.15% 109.79% 131.82% 85.15% 95.59% 126.08% 320.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $45.16M $46.38M $42.61M $8.212M $8.516M $9.391M $7.980M
YoY Change -2.62% 8.85% 418.85% -3.57% -9.32% 17.68%
% of Gross Profit 23.43% 28.24% 30.22% 10.71% 14.48% 27.46% 34.1%
Operating Expenses $306.5M $627.8M $266.7M $123.5M $107.0M $88.22M $82.90M
YoY Change -51.17% 135.35% 116.04% 15.36% 21.32% 6.42%
Operating Profit -$114.5M -$463.5M -$125.7M -$46.78M -$48.20M -$53.98M -$59.50M
YoY Change -75.31% 268.67% 168.78% -2.96% -10.7% -9.28%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018
Interest Expense $5.952M $255.0K -$2.905M -$3.724M -$2.925M -$2.374M -$1.800M
YoY Change 2234.12% -108.78% -21.99% 27.32% 23.21% 31.89%
% of Operating Profit
Other Income/Expense, Net $9.931M -$15.00K -$133.0K -$147.0K -$107.0K -$90.00K $0.00
YoY Change -66306.67% -88.72% -9.52% 37.38% 18.89%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018
Pretax Income -$98.57M -$463.3M -$128.8M -$50.65M -$51.24M -$56.59M -$61.30M
YoY Change -78.72% 259.79% 154.23% -1.15% -9.45% -7.69%
Income Tax $1.235M -$3.624M -$5.639M $4.000K $129.0K $55.00K $0.00
% Of Pretax Income
Net Earnings -$99.81M -$459.7M -$123.1M -$50.65M -$51.37M -$56.50M -$61.30M
YoY Change -78.29% 273.32% 143.08% -1.39% -9.08% -7.84%
Net Earnings / Revenue -24.09% -126.58% -39.71% -29.73% -38.76% -59.59% -79.82%
Basic Earnings Per Share -$1.33 -$6.45 -$1.93 -$1.72 -$9.13
Diluted Earnings Per Share -$1.33 -$6.45 -$1.93 -$1.72 -$9.13 -$1.202M -$1.304M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018
Cash & Short-Term Investments $321.1M $365.9M $433.9M $33.16M $42.70M $13.53M
YoY Change -12.24% -15.68% 1208.46% -22.34% 215.59%
Cash & Equivalents $321.1M $365.9M
Short-Term Investments
Other Short-Term Assets $18.17M $12.48M $8.260M $14.59M $3.750M $2.960M
YoY Change 45.57% 51.13% -43.39% 289.07% 26.69%
Inventory
Prepaid Expenses
Receivables $26.70M $30.80M $11.84M $1.190M $440.0K $6.960M
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $365.9M $409.1M $454.0M $48.94M $46.89M $23.44M
YoY Change -10.56% -9.88% 827.63% 4.37% 100.04%
Property, Plant & Equipment $44.29M $44.92M $9.227M $13.63M $15.27M $21.45M
YoY Change -1.41% 386.86% -32.3% -10.74% -28.81%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.44M $8.883M $7.685M $4.620M $3.600M $2.190M
YoY Change 28.77% 15.59% 66.34% 28.33% 64.38%
Total Long-Term Assets $537.1M $876.4M $21.53M $24.31M $18.87M $23.64M
YoY Change -38.71% 3970.75% -11.44% 28.83% -20.18%
Total Assets $903.1M $1.286B $475.5M $73.25M $65.76M $47.08M
YoY Change
Accounts Payable $10.16M $7.837M $7.390M $5.270M $2.450M $1.630M
YoY Change 29.58% 6.05% 40.23% 115.1% 50.31%
Accrued Expenses $58.37M $47.44M $40.22M $30.42M $22.75M $19.58M
YoY Change 23.06% 17.93% 32.23% 33.71% 16.19%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $600.0K $596.0K $0.00 $4.970M
YoY Change 0.67% -100.0%
Total Short-Term Liabilities $119.4M $111.8M $79.08M $69.96M $56.67M $41.50M
YoY Change 6.86% 41.33% 13.03% 23.45% 36.55%
Long-Term Debt $282.3M $280.7M $0.00 $21.14M $19.20M $15.91M
YoY Change 0.59% -100.0% 10.1% 20.68%
Other Long-Term Liabilities $27.55M $37.32M $5.587M $5.920M $5.850M $6.360M
YoY Change -26.18% 567.91% -5.63% 1.2% -8.02%
Total Long-Term Liabilities $309.9M $318.0M $5.587M $27.06M $25.05M $22.27M
YoY Change -2.55% 5591.46% -79.35% 8.02% 12.48%
Total Liabilities $429.3M $429.7M $84.66M $97.02M $81.72M $63.77M
YoY Change -0.11% 407.59% -12.74% 18.72% 28.15%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018
Basic Shares Outstanding 74.91M shares 71.28M 63.82M 29.37M 5.627M
Diluted Shares Outstanding 74.91M shares 71.28M 63.82M 29.37M 5.627M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $284.3 Million

About Accolade, Inc.

Accolade, Inc. engages in the provision of technology-enabled health and benefits solutions. The company is headquartered in Plymouth Meeting, Pennsylvania and currently employs 2,400 full-time employees. The company went IPO on 2020-07-02. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. The company also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.

Industry: Services-Business Services, NEC Peers: CareMax, Inc. CASTLE BIOSCIENCES INC CROSS COUNTRY HEALTHCARE INC CVS HEALTH Corp DocGo Inc. Enhabit, Inc. Hims & Hers Health, Inc. InnovAge Holding Corp. NATIONAL RESEARCH CORP RadNet, Inc.